NOT-99-098: NIDA INFOFAX AND MISCELLANEOUS COMMUNICATIONS MATERIAL

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.

NIDA INFOFAX AND MISCELLANEOUS COMMUNICATIONS MATERIAL Release Date: May 27, 1999 RFP AVAILABLE: N01DA-9-2064 P.T. National Institute on Drug Abuse The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having in-house capability to provide technical support for enhancing and increasing the availability and accessibility of NIDA information to a broad variety of publics. Specifically, to: (1) further publicize, oversee and refine operation of NIDA’s already successful NIDA INFOFAX system; (2) provide writing work, particularly press and/or publicity- related, as needed; (3) provide Spanish audio and written translations, as needed; (4) provide clear-cut marketing plans for a variety of projects, to establish continuous monthly exposure of NIDA products to the public; (5) provide unique and striking graphics to accompany the marketing and/or products themselves; (6) conduct focus group testing as needed for products; (7) oversee marketing activities, including coordinating placement of products; and (8) provide regular evaluations for effectiveness of the products and of the impact of dissemination and marketing. Organizations submitting proposals should demonstrate extensive experience in public health communications and a high understanding of the capabilities and services from, and products available through, the National Institute on Drug Abuse and other NIH institutes, as well as state-of-the-art fax-on-demand systems. Specifically, organizations submitting should be capable of providing whatever staff and effort are necessary to: (1) demonstrate extensive experience in public health communications; (2) create, through computer graphics, a readily identifiable design for this NIDA service; (3) write and edit, as well as translate into Spanish, scientific material in language easily understood by a broad variety of publics; (4) demonstrate experience in developing marketing strategies and producing marketing and advertising materials; and (5) be capable of ensuring operability of the fax-on-demand system at 99% efficiency. RFP No. N01DA-9-2064 will be available electronically on or about June 17, 1999, and may be accessed through the Internet at the following address: (URL: http://www.nida.nih.gov/RFP/RFPList.html ) Please note that the RFP for this acquisition will be streamlined to include only the Work Statement, Deliverables and Reporting Requirements, Special Requirements and Mandatory Qualifications, Technical Evaluation Criteria, and other necessary Proposal Preparation Instructions. All information required for submission of an offer will be contained in or accessible through the electronic RFP package. Response to the RFP will be due on or about July 16, 1999. This requirement will be a total small business set-aside. Any responsible offeror may submit a proposal which will be considered by the Government. Point of Contact: Michelle L. Scala, Contract Specialist National Institute on Drug Abuse, NIH Contracts Management Branch, OPRM 6001 Executive Boulevard Room 3105, MSC 9543 Bethesda, Maryland 20892-9543 Electronic Mail Address: ms35n@nih.gov Telephone: (301) 443-6677 Fax: (301) 443-7595

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices